Actively Recruiting
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Led by M.D. Anderson Cancer Center · Updated on 2025-11-10
125
Participants Needed
1
Research Sites
249 weeks
Total Duration
On this page
Sponsors
M
M.D. Anderson Cancer Center
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study learn how easily patients can use an educational tool that will be created for patients with melanoma and pre-existing autoimmune diseases who receive or will receive immune checkpoint inhibitor drugs. Patients will be asked their opinions about the design, accessibility, and content of the tool. Researchers will use the information collected to improve the educational materials that will help patients make future decisions about their treatment.
CONDITIONS
Official Title
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of melanoma
- Diagnosis of pre-existing autoimmune disease confirmed by a specialist
- For inflammatory bowel disease: Crohn's disease or ulcerative colitis diagnosis confirmed by a gastroenterologist
- For ulcerative colitis: evidence of chronic changes over 6 months and signs of inflammation histologically
- Treatment for autoimmune disease with medications such as aminosalicylates, corticosteroids, thiopurines, disease-modifying antirheumatic drugs, or targeted therapies
- Age 18 years or older
- Patients recommended to start or currently considering immune checkpoint inhibitor treatment
- Access to email and a computer with Internet or telephone
- Ability to communicate in English or Spanish
- Clinicians providing care for melanoma patients prescribed immune checkpoint inhibitors at MD Anderson clinics
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
A
Angeles Lopez-Olivo
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here